Module 7 · Clinical Chronobiology
Disease & Chronotherapy
The final module pulls together the clinical implications of the previous seven. Time of day matters for when diseases strike, when drugs are most effective, when surgery is safest, and how jet lag and shift work should be managed. Chronotherapy — the deliberate timing of medical interventions to circadian phase — is an emerging clinical discipline with strong mechanistic rationale.
1. Time-of-Day Epidemiology
Major disease events cluster at specific circadian times:
- Myocardial infarction: peaks 6–11 am (Muller 1985). Cortisol peak, platelet activation, and blood pressure rise combine.
- Sudden cardiac death: similar morning peak; 70% higher risk 6am–12pm than overnight.
- Ischaemic stroke: morning peak; atrial fibrillation-associated embolic events often on waking.
- Aortic dissection: peaks 8am–noon.
- Asthma attacks: 4am nadir of peak expiratory flow; nocturnal and early-morning attacks dominate.
- Gout attacks: peak overnight (uric acid solubility falls at low temperature).
- Tonic-clonic seizures: often temporally clustered within individual patients.
2. Shift Work & Disease Risk
~20% of workers in industrialised countries work rotating or night shifts. Meta-analytic risk elevations for chronic shift workers:
- Breast cancer: ~30% elevation in long-term night shift workers (Nurses’ Health Study); WHO/IARC Group 2A classification.
- Type-2 diabetes: ~40% elevation.
- Cardiovascular disease: 20–30% elevation including MI, stroke.
- Metabolic syndrome: ~50% elevation.
- Mood disorders: elevated depression and bipolar risk.
- Pregnancy complications: preterm birth, miscarriage risk modestly elevated.
Mitigation strategies (effective but incomplete): forward-rotating shifts (day-evening-night); bright-light exposure during night shifts; blue-blocking eyewear after night shifts for travel home; scheduled sleep at consistent times on days off; chronotype-based scheduling (owls to nights, larks to mornings).
3. Jet Lag Management
Jet lag: transient circadian disruption after transmeridian travel. Peripheral clocks resynchronise at ~1 h/day; central SCN at ~2 h/day. Eastward travel (requiring phase advance) is harder than westward (requiring phase delay). Therapeutic protocols (Eastman 2009; Sack 2010) use timed light exposure, exogenous melatonin, and sometimes caffeine/modafinil. Pre-trip protocols can partially shift the clock before departure; post-arrival protocols treat based on direction of travel and number of time zones crossed. Smartphone apps (Timeshifter, Entrain) implement these protocols systematically.
4. Drug Pharmacokinetics and Chronotherapy
Drug metabolism varies over the 24-hour cycle because most cytochrome P450s, UGTs, and transporters are clock-regulated. Half-life, Cmax, and AUC can differ by 2–5× between morning and evening dosing. Clinical implementations of chronotherapy:
- Statins: taken in the evening for greatest LDL reduction (cholesterol synthesis peaks at night).
- Antihypertensives: MAPEC (Hermida 2010) and Hygia (Hermida 2019) trials suggested bedtime dosing reduces cardiovascular events by 45–50% vs morning dosing; results controversial and large replication trial (TIME 2022) did not confirm. Open question.
- Chemotherapy: Lévi’s programme for colorectal cancer (5-FU at 04:00, oxaliplatin at 16:00) showed reduced toxicity and improved response in randomised trials (EORTC 05963). Benefit sex-specific (greater in men).
- Immunotherapy: checkpoint-inhibitor infusions earlier in the day correlate with improved overall survival in retrospective melanoma cohorts (Qian 2021) — mechanism putatively through circadian rhythm of T-cell trafficking.
5. Towards Personalised Chronomedicine
The frontier: tailoring interventions to individual chronotype and internal clock state. New tools include BodyTime (Wittenbrink 2018), a blood-transcriptome-based clock phase estimator, and theTimeSignature clock-gene panel. These allow measurement of personal internal time from a single blood sample, opening the prospect of chronotherapy-guided dosing in routine practice. Wearable-based actigraphy and heart-rate-variability estimation of circadian phase are also in development. The next decade will likely bring chronotype and internal phase into the ordinary toolkit of clinical decision-making.
6. Course Synthesis
Eight modules traced the circadian system from founding behavioural experiments through the 2017 Nobel-winning molecular TTFL, central and peripheral clock architecture, light entrainment, circadian regulation of cell cycle and metabolism, sleep and mood, and finally to clinical chronotherapy. The central take-home: a ~24-hour oscillator is a fundamental feature of cellular physiology with pervasive medical relevance. Respecting circadian time — in research, in pharmacology, in public health — is becoming a defining theme of 21st-century medicine.